scholarly journals Concept of “awake venovenous extracorporeal membrane oxygenation” in pediatric patients awaiting lung transplantation

2012 ◽  
Vol 17 (3) ◽  
pp. 224-230 ◽  
Author(s):  
F. Schmidt ◽  
M. Sasse ◽  
M. Boehne ◽  
C. Mueller ◽  
H. Bertram ◽  
...  
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
Pediatric Patients ◽  
Membrane Oxygenation ◽  
Venovenous Extracorporeal Membrane Oxygenation

Early experience of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients with cardiogenic shock

Perfusion ◽  
2020 ◽  
pp. 026765912094132
Author(s):  
Min Ho Ju ◽  
Mi Hee Lim ◽  
Soo Yong Lee ◽  
Chee-Hoon Lee ◽  
Hyung Gon Je
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Pediatric Patients ◽  
Early Experience ◽  
Adult Patients ◽  
Invasive Procedures ◽  
The Third ◽  
Membrane Oxygenation ◽  
Hospital Deaths ◽  
Venovenous Extracorporeal Membrane Oxygenation

Introduction: Pump-controlled retrograde trial off has recently been introduced as an effective method for weaning from veno-arterial extracorporeal membrane oxygenation in pediatric patients. However, studies on pump-controlled retrograde trial off in adults are still lacking. Thus, this study aimed to examine the outcomes of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients. Methods: Between January 2018 and July 2019, 87 consecutive adult patients underwent veno-arterial extracorporeal membrane oxygenation support, of whom 47 (54.0%) underwent pump-controlled retrograde trial off for weaning from extracorporeal membrane oxygenation and were enrolled in this study. The pump-controlled retrograde trial off results, extracorporeal membrane oxygenation reapplication rate, and clinical outcomes were analyzed. Results: Of the 47 patients, 38 (80.9%) were weaned from veno-arterial extracorporeal membrane oxygenation on the first attempt of pump-controlled retrograde trial off, 5 (10.6%) on the second attempt, and 4 (8.5%) on the third attempt. Three patients were converted to venovenous extracorporeal membrane oxygenation by desaturation but had stable blood pressure during pump-controlled retrograde trial off. No extracorporeal membrane oxygenation reapplication was performed within 3 days after removal, and two patients underwent veno-arterial extracorporeal membrane oxygenation during follow-up. No complications associated with pump-controlled retrograde trial off occurred during the weaning process, including thromboembolic events. Five in-hospital deaths (10.6%) occurred after weaning from extracorporeal membrane oxygenation. Conclusion: Pump-controlled retrograde trial off is an effective method to safely wean from veno-arterial extracorporeal membrane oxygenation in adult patients. It is simple and can be easily implemented without additional invasive procedures and may help prevent deterioration of the cardiovascular system after weaning from veno-arterial extracorporeal membrane oxygenation.

Buying time: The use of extracorporeal membrane oxygenation as a bridge to lung transplantation in pediatric patients

2013 ◽  
Vol 17 (8) ◽  
pp. E182-E188 ◽  
Author(s):  
Georgina K. Casswell ◽  
David V. Pilcher ◽  
Rani S. Martin ◽  
Vincent A. Pellegrino ◽  
Silvana F. Marasco ◽  
...  
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
Pediatric Patients ◽  
Membrane Oxygenation

scholarly journals Heparin-Free Lung Transplantation on Venovenous Extracorporeal Membrane Oxygenation Bridge

ASAIO Journal ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Vittorio Scaravilli ◽  
Jacopo Fumagalli ◽  
Lorenzo Rosso ◽  
Federico Polli ◽  
Mauro Panigada ◽  
...  
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
Membrane Oxygenation ◽  
Venovenous Extracorporeal Membrane Oxygenation
Sign in / Sign up

Export Citation Format

Share Document